BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 7352085)

  • 1. Intrauterine device termination rates and the menstrual cycle day of insertion.
    White MK; Ory HW; Rooks JB; Rochat RW
    Obstet Gynecol; 1980 Feb; 55(2):220-4. PubMed ID: 7352085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wider opportunities for IUD insertion.
    Cole LP; Potts DM
    IPPF Med Bull; 1983 Feb; 17(1):2-3. PubMed ID: 12264751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Which stage of the menstrual cycle in best suited for the insertion of IUD?].
    Havránek F
    Cesk Gynekol; 1978 Jul; 43(6):447. PubMed ID: 679301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of safety and efficacy of IUD insertions by physicians and nursing personnel in Brazil.
    Lassner KJ; Chen CH; Kropsch LA; Oberle MW; Lopes IM; Morris L
    Bull Pan Am Health Organ; 1995 Sep; 29(3):206-15. PubMed ID: 8520606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Timing of the IUD insertion.
    Edelman DA; Zipper J; Rivera M; Medel M
    Contraception; 1979 May; 19(5):449-54. PubMed ID: 467054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrauterine devices.
    Mccarthy TG; Ratnam SS
    Contemp Rev Obstet Gynaecol; 1992 Oct; 4(4):215-22. PubMed ID: 12345158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immediate postabortion intrauterine contraception in nulliparous adolescents.
    Goldman JA; Dekel A; Reichman J
    Isr J Med Sci; 1979 Jun; 15(6):522-5. PubMed ID: 457386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The TCu380 IUD: initial international experimental results with the latest "T" family IUD].
    Elia D; Belaisch J
    Contracept Fertil Sex (Paris); 1985 Sep; 13(9):973-8. PubMed ID: 12267501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postpartum insertion of modified intrauterine devices.
    Cole LP; Edelman DA; Potts DM; Wheeler RG; Laufe LE
    J Reprod Med; 1984 Sep; 29(9):677-82. PubMed ID: 6387112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Four years' experience with the TCu 220C, a long-acting multisleeved copper intrauterine device.
    Thiery M; Van Der Pas H; Van Kets H; Boogers W; Haspels A; Amy J-j
    Adv Plan Parent; 1979; 14(1):21-6. PubMed ID: 12335870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of side-effects of Cu-T as intra-uterine contraceptive device in post medical termination of pregnancy and interval cases.
    Das CR; Pradhan G
    J Indian Med Assoc; 1995 Oct; 93(10):375-6. PubMed ID: 9053409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficiency and acceptability of intrauterine contraceptive devices.
    Trutko NS
    Acta Med Hung; 1986; 43(2):103-8. PubMed ID: 3588154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statement on intrauterine devices (IUDs).
    International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP
    IPPF Med Bull; 1987 Dec; 21(6):3-5. PubMed ID: 12268853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intrauterine contraception with copper-T 200 device- a retrospective analysis of 334 cases (author's transl)].
    Salzer H; Schneider WH; Eppel W
    Wien Klin Wochenschr; 1981 May; 93(11):354-8. PubMed ID: 7269615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of modified intrauterine device (IUD) TCu 380 with chromium filaments in the immediate postpartum].
    Hernández Valencia M; Becerril Flores LC
    Ginecol Obstet Mex; 2000 Feb; 68():70-6. PubMed ID: 10774108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copper intrauterine device use by nulliparous women: review of side effects.
    Hubacher D
    Contraception; 2007 Jun; 75(6 Suppl):S8-11. PubMed ID: 17531622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performances of copper T 380A and multiload copper 375/250 intrauterine contraceptive devices in a comparative clinical trial.
    Arowojolu AO; Otolorin EO; Ladipo OA
    Afr J Med Med Sci; 1995 Mar; 24(1):59-65. PubMed ID: 7495202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of copper T as contraceptive after caesarean section.
    Parikh V; Gandhi AS
    J Indian Med Assoc; 1989 May; 87(5):113-5. PubMed ID: 2600433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Secondary effects and complications of new intra-uterine devices (author's transl)].
    Revaz C
    Schweiz Rundsch Med Prax; 1981 Mar; 70(13):561-7. PubMed ID: 7232307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.